Segregating DNA lesions point to high selective advantage of tumor initiating cells.

Seplyarskiy V, Shady M, Andrianova MA, Chapman MS, Van Allen EM, Sunyaev SR.

Shamil Sunyaev

bioRxiv

October 4, 2025

http://www.ncbi.nlm.nih.gov/pubmed/41256703

https://connects.catalyst.harvard.edu/Profiles/profile/322968629

Segregating DNA lesions point to high selective advantage of tumor initiating cells.

Seplyarskiy V, Shady M, Andrianova MA, Chapman MS, Van Allen EM, Sunyaev SR.

Shamil Sunyaev

bioRxiv

October 4, 2025

http://www.ncbi.nlm.nih.gov/pubmed/41256703

https://connects.catalyst.harvard.edu/Profiles/profile/322968629